SCHEMBL10312990

SCHEMBL10312990

CCc1cnc2c(c1)CN(C(=O)c1ccccc1)CC2

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.54
PDGFRB P09619 2/20 0.48
KDR P35968 1/20 0.48
HPGD P15428 6/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
MAPT P10636 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
BLM P54132 1/20 0.43
GRM5 P41594 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ESR1 P03372 1/20 0.42
PDE4B Q07343 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10312997 0.89 PTGS1 (0.55) PTGS1PDGFRBKDRHPGDCYP3A4
SCHEMBL10313097 0.85 PTGS1 (0.51) PTGS1PDGFRBKDRGRM5ALDH1A1
SCHEMBL13226307 0.83 PTGS1 (0.58) PTGS1PDGFRBKDRHPGDSMN1; SMN2
SCHEMBL10312992 0.81 HPGD (0.57) PTGS1PDGFRBKDRHPGDSMN1; SMN2
SCHEMBL13226306 0.81 PTGS1 (0.60) PTGS1PDGFRBKDRHPGDCYP3A4
SCHEMBL10312999 0.81 NPC1 (0.36) PDGFRBKDRHPGDCYP2C19HTT
SCHEMBL10312991 0.81 PTGS1 (0.54) PTGS1PDGFRBKDRHPGDCYP3A4
SCHEMBL10312985 0.81 KCNA5 (0.48) PTGS1HPGDHTTMAPTGRM5
SCHEMBL10313047 0.81 PTGS1 (0.51) PTGS1PDGFRBKDRHPGDCYP3A4
SCHEMBL13253558 0.80 PTGS1 (0.55) PTGS1PDGFRBKDRHPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178776-A1 DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178776-A1 DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS GRM5, GRIK5, GRM3 PTGS1 3011/4885PDGFRB 4080/4885KDR 4538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.